131 related articles for article (PubMed ID: 37349996)
1. Improved Antitumor Efficacy of a Dextran-based Docetaxel-coupled Conjugate against Triple-Negative Breast Cancer.
Lv H; Jia W; Dong P; Liu J; Wang S; Li X; Hu J; Zhao L; Shi Y
Curr Drug Deliv; 2024; 21(5):775-784. PubMed ID: 37349996
[TBL] [Abstract][Full Text] [Related]
2. A Novel Dextran-Based Dual Drug Conjugate Targeted Tumors with High Biodistribution Ratio of Tumors to Normal Tissues.
Liu J; Zhang N; Wu J; Dong P; Lv H; Wang Q; Wang S; Yang H; Wang S; Li X; Hu J; Wang A; Li DJ; Shi Y
Int J Nanomedicine; 2022; 17():4895-4910. PubMed ID: 36262192
[TBL] [Abstract][Full Text] [Related]
3. The enhanced antitumor activity of the polymeric conjugate covalently coupled with docetaxel and docosahexaenoic acid.
Dong P; Liu J; Lv H; Wu J; Zhang N; Wang S; Li X; Hu J; Wang A; Li DJ; Wang D; Cao S; Xie L; Shi Y
Biomater Sci; 2022 Jun; 10(13):3454-3465. PubMed ID: 35647736
[TBL] [Abstract][Full Text] [Related]
4. Polysaccharide dextran-based conjugate for selective co-delivery of two synergistic drugs docetaxel and docosahexaenoic acid to tumor cells.
Dong P; Lv H; Jia W; Liu J; Wang S; Li X; Hu J; Zhao L; Shi Y
Drug Deliv; 2023 Dec; 30(1):40-50. PubMed ID: 36458324
[TBL] [Abstract][Full Text] [Related]
5. Synthesis, characterization, and in vivo efficacy evaluation of PGG-docetaxel conjugate for potential cancer chemotherapy.
Yang D; Van S; Shu Y; Liu X; Ge Y; Jiang X; Jin Y; Yu L
Int J Nanomedicine; 2012; 7():581-9. PubMed ID: 22334784
[TBL] [Abstract][Full Text] [Related]
6. A pH-responsive carboxymethyl dextran-based conjugate as a carrier of docetaxel for cancer therapy.
Han HS; Lee M; An JY; Son S; Ko H; Lee H; Chae YS; Kang YM; Park JH
J Biomed Mater Res B Appl Biomater; 2016 May; 104(4):789-96. PubMed ID: 26687579
[TBL] [Abstract][Full Text] [Related]
7. Therapeutic efficacy of lipid emulsions of docetaxel-linoleic acid conjugate in breast cancer.
Zhang T; Li M; Yang R; Zhang D; Guan J; Yu J; Yang B; Zhang H; Zhang S; Liu D; Wang Y
Int J Pharm; 2018 Jul; 546(1-2):61-69. PubMed ID: 29763687
[TBL] [Abstract][Full Text] [Related]
8. Complete regression of xenografted breast tumors by dextran-based dual drug conjugates containing paclitaxel and docosahexaenoic acid.
Wang S; Liu J; Lv H; Huang X; Dong P; Wang Q; Yang H; Wang S; Li X; Hu J; Wang D; Cao S; Xie L; Shi Y
Eur J Med Chem; 2022 Oct; 240():114567. PubMed ID: 35779290
[TBL] [Abstract][Full Text] [Related]
9. Pharmacokinetics and in vitro/in vivo antitumor efficacy of aptamer-targeted Ecoflex
Ghassami E; Varshosaz J; Jahanian-Najafabadi A; Minaiyan M; Rajabi P; Hayati E
Int J Nanomedicine; 2018; 13():493-504. PubMed ID: 29416331
[TBL] [Abstract][Full Text] [Related]
10. Hyaluronan-based nanocarriers with CD44-overexpressed cancer cell targeting.
Song S; Qi H; Xu J; Guo P; Chen F; Li F; Yang X; Sheng N; Wu Y; Pan W
Pharm Res; 2014 Nov; 31(11):2988-3005. PubMed ID: 24842660
[TBL] [Abstract][Full Text] [Related]
11.
Kazemi M; Emami J; Hasanzadeh F; Minaiyan M; Mirian M; Lavasanifar A; Mokhtari M
Recent Pat Anticancer Drug Discov; 2020; 15(4):341-359. PubMed ID: 33023456
[TBL] [Abstract][Full Text] [Related]
12. Tumor-specific delivery and therapy by double-targeted DTX-CMCS-PEG-NGR conjugates.
Liu F; Li M; Liu C; Liu Y; Liang Y; Wang F; Zhang N
Pharm Res; 2014 Feb; 31(2):475-88. PubMed ID: 24043295
[TBL] [Abstract][Full Text] [Related]
13. The structure of polymer carriers controls the efficacy of the experimental combination treatment of tumors with HPMA copolymer conjugates carrying doxorubicin and docetaxel.
Šírová M; Strohalm J; Chytil P; Lidický O; Tomala J; Říhová B; Etrych T
J Control Release; 2017 Jan; 246():1-11. PubMed ID: 27940304
[TBL] [Abstract][Full Text] [Related]
14. Antitumor activity of docetaxel-loaded polymeric nanoparticles fabricated by Shirasu porous glass membrane-emulsification technique.
Yu Y; Tan S; Zhao S; Zhuang X; Song Q; Wang Y; Zhou Q; Zhang Z
Int J Nanomedicine; 2013; 8():2641-52. PubMed ID: 23935362
[TBL] [Abstract][Full Text] [Related]
15. Drug-interactive mPEG-
Gong F; Wang R; Zhu Z; Duan J; Teng X; Cui ZK
Drug Deliv; 2020 Dec; 27(1):238-247. PubMed ID: 32003299
[TBL] [Abstract][Full Text] [Related]
16. Blood-brain barrier-penetrating amphiphilic polymer nanoparticles deliver docetaxel for the treatment of brain metastases of triple negative breast cancer.
He C; Cai P; Li J; Zhang T; Lin L; Abbasi AZ; Henderson JT; Rauth AM; Wu XY
J Control Release; 2017 Jan; 246():98-109. PubMed ID: 28017889
[TBL] [Abstract][Full Text] [Related]
17. Efficient in vitro and in vivo docetaxel delivery mediated by pH-sensitive LPHNPs for effective breast cancer therapy.
Jadon RS; Sharma G; Garg NK; Tandel N; Gajbhiye KR; Salve R; Gajbhiye V; Sharma U; Katare OP; Sharma M; Tyagi RK
Colloids Surf B Biointerfaces; 2021 Jul; 203():111760. PubMed ID: 33872827
[TBL] [Abstract][Full Text] [Related]
18. Tumor targetability and antitumor effect of docetaxel-loaded hydrophobically modified glycol chitosan nanoparticles.
Hwang HY; Kim IS; Kwon IC; Kim YH
J Control Release; 2008 May; 128(1):23-31. PubMed ID: 18374444
[TBL] [Abstract][Full Text] [Related]
19. AS1411 Aptamer/Hyaluronic Acid-Bifunctionalized Microemulsion Co-Loading Shikonin and Docetaxel for Enhanced Antiglioma Therapy.
Wang H; Zhu Z; Zhang G; Lin F; Liu Y; Zhang Y; Feng J; Chen W; Meng Q; Chen L
J Pharm Sci; 2019 Nov; 108(11):3684-3694. PubMed ID: 31465736
[TBL] [Abstract][Full Text] [Related]
20. Design of theranostic nanomedicine (II): synthesis and physicochemical properties of a biocompatible polyphosphazene-docetaxel conjugate.
Jun YJ; Park JH; Avaji PG; Park KS; Lee KE; Lee HJ; Sohn YS
Int J Nanomedicine; 2017; 12():5373-5386. PubMed ID: 28794629
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
